Carol Giltner Gallagher Mirati Therapeutics, Inc. (MRTX) insider trading activity

Carol Giltner Gallagher is of Mirati Therapeutics, Inc.. Currently has a direct ownership of 0 shares of MRTX, which is worth approximately $0. The most recent transaction as insider was on Jan 23, 2024, when has been sold 14,363 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

100.0% 12M change

Total Value Held $0

Carol Giltner Gallagher Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 23 2024	SELL Sale (or disposition) back to the issuer	-	14,363 Reduced 100.0%	0 Common Stock
Dec 29 2023	BUY Grant, award, or other acquisition	$399,970 $58.75 p/Share	6,808 Added 32.16%	14,363 Common Stock
Jun 22 2023	BUY Grant, award, or other acquisition	-	7,555 Added 50.0%	7,555 Common Stock

Also insider at

TPTX

Turning Point Therapeutics, Inc.

Director

ATRA

Atara Biotherapeutics, Inc. Healthcare

CERT

Certara, Inc. Healthcare

PMVP

PMV Pharmaceuticals, Inc. Healthcare

FLAC

Frazier Lifesciences Acquisition Corp Financial Services

Director

CGG